Showing results (601-610 of 673) with videos related to

Sort By:
Pageof 68
Nature Communications|August 21, 2024
Adipose tissue macrophage infiltration and hepatocyte stress increase GDF-15 throughout development of obesity to MASHLaurent L'homme, Benan Pelin Sermikli, Joel T Haas, et al.
Hepatology Communications|March 7, 2020
Pirfenidone Is an Agonistic Ligand for PPARα and Improves NASH by Activation of SIRT1/LKB1/pAMPKAna Sandoval-Rodriguez, Hugo Christian Monroy-Ramirez, Alejandra Meza-Rios, et al.
Pharmacological Reviews|November 30, 2006
International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptorsLiliane Michalik, Johan Auwerx, Joel P Berger, et al.
Diabetes|May 20, 2011
Farnesoid X receptor deficiency improves glucose homeostasis in mouse models of obesityJanne Prawitt, Mouaadh Abdelkarim, Johanna H M Stroeve, et al.
Angewandte Chemie (International Ed. in English)|February 28, 2025
LIBX-A401: A Novel Selective Inhibitor of Acyl-CoA Synthetase Long Chain Family Member 4 (ACSL4) and Its Binding ModeDarius Mazhari Dorooee, Séverine Ravez, Didier Vertommen, et al.
Metabolism: Clinical and Experimental|November 5, 2023
The ubiquitin-like modifier FAT10 is induced in MASLD and impairs the lipid-regulatory activity of PPARαLudivine Clavreul, Lucie Bernard, Alexia K Cotte, et al.
Scientific Reports|January 15, 2020
The nuclear receptor FXR inhibits Glucagon-Like Peptide-1 secretion in response to microbiota-derived Short-Chain Fatty AcidsSarah Ducastel, Véronique Touche, Mohamed-Sami Trabelsi, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 25, 2010
Transcriptional activation of apolipoprotein CIII expression by glucose may contribute to diabetic dyslipidemiaSandrine Caron, An Verrijken, Ilse Mertens, et al.
Pageof 68